CORIXA CORP
10-Q, EX-27.1, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CORIXA CORP, 10-Q, EX-3.3, 2000-08-14
Next: DENISON INTERNATIONAL PLC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          21,709
<SECURITIES>                                    75,493
<RECEIVABLES>                                    3,442
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                98,086
<PP&E>                                          20,676
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 142,371
<CURRENT-LIABILITIES>                           27,377
<BONDS>                                          9,726
                            2,000
                                          0
<COMMON>                                            21
<OTHER-SE>                                     103,247
<TOTAL-LIABILITY-AND-EQUITY>                   142,371
<SALES>                                              0
<TOTAL-REVENUES>                                16,191
<CGS>                                                0
<TOTAL-COSTS>                                   36,082
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (341)
<INCOME-PRETAX>                               (18,166)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (18,166)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (18,166)
<EPS-BASIC>                                     (0.94)
<EPS-DILUTED>                                   (0.94)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission